Overactive Bladder - Results from #380

REVIEW UroToday

Efficacy and Safety of DA-8010, a Novel M3 Antagonist, in Patients With Overactive Bladder: A Randomized, Double-Blind Phase 2 Study. July 10, 2022

Evaluation of pelvic floor muscle elasticity in patients with overactive bladder syndrome using real-time tissue elastography. July 10, 2022

Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland July 5, 2022

Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis. July 3, 2022

Correlation between overactive bladder and detrusor overactivity: a retrospective study. July 3, 2022

How effectively do we apply first-line treatment in overactive bladder? July 3, 2022

The three-year evolution of overactive bladder syndrome in community-dwelling female residents aged 40 years and above. June 26, 2022

Synchronous Telemedicine Model in Urogynecology: Are Patients Willing to Continue Telemedicine in the Post-COVID-19 Pandemic Era? June 26, 2022

Does COVID-19 Vaccination Cause Storage Lower Urinary Tract Symptoms? June 19, 2022

Does metabolic syndrome influence the efficacy of mirabegron treatment in female patients with overactive bladder? June 19, 2022

The association between overactive bladder and fibromyalgia: A systematic review and meta-analysis. June 19, 2022

UroViu Launches New Single-Use Hysteroscope June 15, 2022

Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review. June 12, 2022

Dementia Associated with Anticholinergic Drugs Used for Overactive Bladder: A Nested-Case Control Study Using the French National Medical-Administrative Database. June 12, 2022

Vibegron for the Treatment of Patients with Dry and Wet Overactive Bladder: A Subgroup Analysis from the EMPOWUR Trial. June 12, 2022

Biofeedback-assisted pelvic floor muscle training and pelvic electrical stimulation in women with overactive bladder: A systematic review and meta-analysis of randomized controlled trials. June 12, 2022

Bright Uro Launches with $6 Million in Seed Financing and Grant from National Institutes of Health June 9, 2022

A Multi-Center, Randomized, Blind, Controlled Clinical Trial of the Safety and Efficacy of Micro Radio Frequency Therapy System for the Treatment of Overactive Bladder. June 5, 2022

Third-line therapy for overactive bladder in the elderly: Nuances and considerations. June 5, 2022

Sacral Neuromodulation Using a Novel Device with a Six-contact-point Electrode for the Treatment of Patients with Refractory Overactive Bladder: A Multicenter, Randomized, Single-blind, Parallel-control Clinical Trial. May 29, 2022

Page 20 of 121